C. Ramesh et al. / Tetrahedron Letters 51 (2010) 5234–5237
5237
2. (a) Hofmann, A. W. v. Ber. 1881, 14, 2725; (b) Mason, C. D.; Kord, F. F. J. Org.
Chem. 1951, 16, 1869; (c) MacDonald, D. L.; Fischer, H. O. L. J. Am. Chem. Soc.
1952, 74, 2087; (d) Shioiri, T. Comp. Org. Synth. 1991, 6, 800; (e) Richter, L. S.;
Andersen, S. Tetrahedron Lett. 1998, 39, 8747; (f) Hourdin, G.; Germain, A.;
Moreau, C.; Fajula, F. J. Catal. 2002, 209, 217; (g) Dickstein, J. S.; Mulrooney, C.
A.; O’Brien, E. M.; Morgan, B. J.; Kozlowski, M. C. Org. Lett. 2007, 9, 2441; (h)
Stapley, J. A.; BeMiller, J. N. Carbohydr. Res. 2007, 342, 407; (i) Goossen, L. J.;
Rodriguez, N.; Linder, C. J. Am. Chem. Soc. 2008, 130, 15248; (j) Lebreux, F.;
Buzzo, F.; Markó, I. E. Synlett 2008, 2815; (k) Jana, R.; Trivedi, R.; Tunge, J. A. Org.
Lett. 2009, 11, 3434; (l) Gao, S.; Tseng, C.; Raju, B. R.; Hsuan, C. T.; Yao, C.-F.
Synlett 2009, 3201.
3. (a) Belotti, D.; Andreatta, G.; Pradaux, F.; Bouz, S. B.; Cossy, J. Tetrahedron Lett.
2003, 44, 3613; (b) Taira, S.; Danjo, H.; Imamoto, T. Tetrahedron Lett. 2002, 43,
8893; (c) Itoh, K.; Ishida, H.; Chikashita, H. Chem. Lett. 1982, 1117; (d) Varma,
M.; Stirling, C. J. M. J. Chem. Soc., Chem. Commun. 1981, 553.
4. (a) Yadav, L. D. S.; Rai, A. Synlett 2009, 1067; (b) Erker, T.; Schreder, M. E.;
Studenik, C. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 58; (c) Schreder, M. E.;
Erker, T. J. Heterocycl. Chem. 2000, 37, 349; (d) Jonsson, S.; Arribas, C. S.; Wendt,
O. F.; Siegel, J. S.; Warnmark, K. Org. Biomol. Chem. 2005, 3, 996; (e) Aiello, E.;
Dattolo, G.; Cirrincione, G. J. Chem. Soc., Perkin Trans. 1 1981, 1.
5. (a) Mishra, J. K.; Panda, G. Synlett 2005, 1881; (b) Kamal, A.; Reddy, B. S. P.;
Reddy, B. S. N. Tetrahedron Lett. 1996, 37, 2281.
6. (a) Basavaiah, D.; Rao, J. S. Tetrahedron Lett. 2004, 45, 1621; (b) Lee, M. J.; Lee, K.
Y.; Park, D. Y.; Kim, J. N. Bull. Korean Chem. Soc. 2005, 26, 1281; (c) Lee, K. Y.; Lee,
Y.; Kim, J. N. Bull. Korean Chem. Soc. 2007, 28, 143.
7. Scribner, A.; Moore, J. A., III; Ouvry, G.; Fisher, M.; Wyvratt, M.; Leavitt, P.;
Liberator, P.; Gurnett, A.; Brown, C.; Mathew, J.; Thompson, D.; Schmatz, D.;
Biftu, T. Bioorg. Med. Chem. Lett. 2009, 19, 1517.
8. (a) Basavaiah, D.; Srivardhana Rao, J.; Raju, J. J. Org. Chem. 2004, 69, 7379; (b)
Basavaiah, D.; Reddy, R. M.; Kumaragurubaran, N.; Sharada, D. S. Tetrahedron
2002, 58, 3693; (c) Basavaiah, D.; Raju, J.; Rao, J. S. Tetrahedron Lett. 2006, 47, 73.
9. (a) Gildchrist, T. L. Six-membered Ring Compounds with One Heteroatom, 1st ed.;
Pitman Publishing Ltd: London, 1985; (b) Lednicer, D.; Mitscher, L. A.. In The
Organic Chemistry of Drug Synthesis; Wiley-Interscience: New York, 1977; Vol.
. p 337; (c) Joshi, A. A.; Narkhede, S. S.; Viswanathan, C. L. Bioorg. Med. Chem.
Lett. 2005, 15, 73; (d) Roma, G.; Di Braccio, M.; Grossi, G.; Mattioli, F.; Ghia, M.
Eur. J. Med. Chem. 2000, 35, 1021; (e) Dube, D.; Blouin, M.; Brideau, C.; Chan, C.
C.; Desmarais, S.; Ethier, D.; Falgueyret, J. P.; Friesen, R. W.; Girard, M.; Girard,
Y.; Guay, J.; Riendeau, D.; Tagari, P.; Young, R. N. Bioorg. Med. Chem. Lett. 1998,
8, 1255; (f) Narender, P.; Srinivas, U.; Ravinder, M.; Rao, B. A.; Ramesh, C.;
Harakishore, K.; Gangadasu, B.; Murthy, U. S. N.; Rao, V. J. Bioorg. Med. Chem.
2006, 14, 4600; (g) Muruganantham, N.; Sivakumar, R.; Anbalagan, N.;
Gunasekaran, V.; Leonard, J. T. Biol. Pharm. Bull. 2004, 27, 1683; (h)
Martirosyan, A. R.; Rahim-Bata, R.; Freeman, A. B.; Clarke, C. D.; Howard, R.
L.; Strobl, J. S. Biochem. Pharmacol. 2004, 68, 1729; (i) Maguire, M. P.; Sheets, K.
R.; McVety, K.; Spada, A. P.; Zilberstein, A. J. Med. Chem. 1994, 37, 2129.
10. (a) Aggarwal, A. K.; Jenekhe, S. A. Macromolecules 1991, 24, 6806; (b) Zhang, X.;
Shetty, A. S.; Jenekhe, S. A. Macromolecules 1999, 32, 7422; (c) Jenekhe, S. A.; Lu,
L.; Alam, M. M. Macromolecules 2001, 34, 7315.
11. (a) Nalwa, H. S.; Suzuki, M.; Takahashi, A.; Kageyama, A. Appl. Phys. Lett. 1998,
72, 1311; (b) Concilio, S.; Pfister, P. M.; Tirelli, N.; Kocher, C.; Suter, U. W.
Macromolecules 2001, 34, 3607.
12. (a) Camps, R. Arch. Pharm. 1899, 237, 659; (b) Pflum, D. A. In Camps Quinolinol
Synthesis in Name Reactions in Heterocyclic Chemistry; Li, J. J., Corey, E. J., Eds.;
Wiley & Sons: Hoboken, NJ, 2005; p 386; (c) Skraup, H. Ber. Dtsch. Chem. Ges.
1880, 13, 2086; (d) Friedlander, P. Ber. Dtsch. Chem. Ges. 1882, 15, 2572; (e)
Manske, R. H. F.; Kulka, M. Org. React. 1953, 7, 59; (f) Fehnel, E. A. J. Heterocycl.
Chem. 1967, 4, 565; (g) Cheng, C.-C.; Yan, S.-J. Org. React. 1982, 28, 37; (h) Jones,
G.. In Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. W.,
Scriven, E. F. V., Eds.; Pergamon: New York, 1996; Vol. 5, p 167.
13. (a) Ramesh, C.; Kavala, V.; Raju, B. R.; Kuo, C. W.; Yao, C. F. Tetrahedron Lett.
2009, 50, 4037; (b) Ramesh, C.; Kavala, V.; Kuo, C. W.; Raju, B. R.; Yao, C. F. Eur.
J. Org. Chem. 2010, 3796.
14. (a) List, B.; Pojarliev, P.; Martin, H. J. Org. Lett. 2001, 16, 2423; (b) Saraswathi, V.
G.; Sankararaman, S. J. Org. Chem. 1995, 60, 5024.
15. To a stirred solution of 4-nitro-3-(2-nitrophenyl)butan-2-one 1 (1 mmol) in
acetic acid (5 mL), powdered Fe (6 mmol) was added and the reaction mixture
was refluxed for 2 h. The mixture was cooled to room temperature and the
acetic acid was removed under reduced pressure, EtOAc (10 mL) was added,
then the mixture was stirred for 2 min and then filtered to remove any iron
impurities. The insoluble iron residue was washed with EtOAc (10 mL). The
filtrate and washings were combined and dried over anhydrous MgSO4. The
solvent was removed under reduced pressure and the crude product was
purified by flash column chromatography (petroleum ether/ethyl acetate) to
yield the expected product.
16. Spectral data: 1,2,3,4-tetrahydroacridine (11a): White solid; mp: 46–48 °C. 1H
NMR (400 MHz, CDCl3) d 7.97 (d, J = 8.3 Hz, 1H), 7.79 (s, 1H), 7.68 (d, J = 8.0 Hz,
1H), 7.61–7.57 (m, 1H), 7.44–7.40 (m, 1H), 3.12 (t, J = 6.5 Hz, 2 H), 2.97 (t,
J = 6.1 Hz, 2H), 2.02–1.96 (m, 2H), 1.92–1.87 (m, 2H). 13C NMR (100 MHz,
CDCl3) d 159.0, 146.4, 134.8, 130.7, 128.3, 128.1, 127.0, 126.7, 125.3, 33.4, 29.0,
23.0, 22.7. MS (EI) (m/z) (relative intensity) 183(M+, 100), 182(40). HRMS calcd
for
C13H13N
(M+) 183.1043 found 183.1037. 8-Fluoro-3,4-dihydro-1H-
pyrano[4,3-b]quinoline (15a): White solid; mp: 107–109 °C. 1H NMR
(400 MHz, CDCl3) d 7.99 (dd, J = 8.2, 5.3 Hz, 1H), 7.70 (s, 1H), 7.45–7.40 (m,
1H), 7.34 (dd, J = 8.8, 2.6 Hz, 1H), 4.95 (s, 2H), 4.17 (t, J = 5.9 Hz, 2H), 3.21 (t,
J = 5.8 Hz, 2H). 13C NMR (100 MHz, CDCl3) d 160.2 (d, J = 246.0 Hz), 154.4,
144.1, 130.9 (d, J = 10.0 Hz), 130.3 (d, J = 5.0 Hz), 129.5, 127.3 (d, J = 10.0 Hz),
119.4 (d, J = 26.0 Hz), 110.1 (d, J = 21.0 Hz), 67.7, 65.9, 32.6. MS (EI) (m/z)
(relative intensity) 203 (M+, 100), 173(27). HRMS calcd for C12H10FNO (M+)
203.0741 found 203.0735.